Day: August 11, 2023

JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) — via IBN – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, announced the publication today of its financial results for the second quarter ended June 30, 2023, and provided a business update. Second Quarter 2023 Financial SummaryR&D expenses for the three months ended June 30, 2023, amounted to $1.45 million compared with $1.97 million for the three months ended June 30, 2022. Marketing, general and administrative expenses for the three months ended June 30, 2023, amounted to $1.14 million compared with $1.29 million for the three months ended June 30, 2022. Total operating expenses for the...

CALGARY, Alberta, Aug. 11, 2023 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX: SFD; OTCQB: NSFDF) today announced the Company’s financial and operating results for the three and six months ended June 30, 2023. All dollar amounts herein are in Canadian Dollars unless otherwise identified. Financial and Operating Highlights Key financial and operational highlights are summarized below:On May 24 the Company entered into a ten year strategic alliance in Africa with Synergy E&P Technologies Limited (“Synergy”) which grants Synergy an exclusive license to use, distribute, sub-license, market and sell NXT’s SFD® solutions in Africa; At the same time the Company entered into a US$2.3 million convertible debenture financing with Ataraxia Capital, an affiliate of Synergy....

Maha Energy AB (publ) (“Maha” or the “Company”) is pleased to announce its second quarter 2023 results. The report is attached to this press release and available on the Company’s website at www.mahaenergy.ca. Second Quarter 2023All amounts are in US dollars unless otherwise noted. The amounts below are related only to continuing operations.The Company completed the business combination with DBO 2.0 S.A., holding 15% equity interest in 3R Offshore. Income from investment in associate amounted to 0.4 million (Q2 2022: nil), representing Maha’s share of results in 3R Offshore for the month of June. Daily oil production for Q2 2023 from continuing operations averaged 211 BOEPD (Q2 2022: 542 BOEPD) and including non-consolidated production from 3R Offshore averaged 1,988 BOEPD. Revenue of 1.3 million (Q2 2022: 4.1 million) following lower...

ELI-002 2P positive interim data from AMPLIFY-201 Phase 1 study presented at ASCO AMPLIFY-7P first patient dosed with ELI-002 7P Completed reverse merger becoming a publicly traded company on Nasdaq Anticipate releasing additional AMPLIFY-201 clinical data in second half 2023BOSTON, Aug. 11, 2023 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today reported financial results for the second quarter ended June 30, 2023 and provided recent corporate and clinical updates. “The second quarter represented a transformative period for Elicio as we became a public company and reported interim results for the first-in-human clinical trial of our cancer vaccine candidate ELI-002,” said Robert Connelly, Chief...

Well positioned for growth with cash and cash equivalents of $21.4 million and no outstanding debt Consolidated gross profit increased by 7.5% in Q2 2023 versus Q2 2022 OLD GREENWICH, Conn., Aug. 11, 2023 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified holding company, reported today its financial results for the second quarter (Q2) ended June 30, 2023. All 2023 and 2022 amounts in this release are unaudited. Following the sale of our Digirad Health business on May 4, 2023, all financial results for the 2023 and 2022 reporting periods, unless stated otherwise, relate to continuing operations, which currently include two divisions: Construction and Investments. Q2 2023 Financial Highlights vs. Q2 2022 (unaudited)Revenues decreased by 47.1% to $8.9 million from...

Achieved significant enrollment milestone in pivotal Phase 3 trial of IO102-IO103 cancer vaccine in advanced melanoma; full enrollment anticipated by the end of 2023 Initiated enrollment in three investigator-initiated trials which the company is supporting to evaluate IO102-IO103 in combination regimens across a variety of cancer types Continued enrollment in Phase 2 basket trial of IO102-IO103, in patients with lung cancer, and head and neck cancer Strengthened executive team with hires to key commercial and medical leadership positions Completed a $75 million private placement with participation from both new and existing healthcare-dedicated investors Ended the second quarter with approximately $110.1 million in cash and cash equivalents, which, together with the proceeds from the private placement financing, is expected to support...

LAS VEGAS, NV, Aug. 11, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Golden Matrix Group Inc. (NASDAQ:GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content, today announced it had achieved record third quarter (ending July 31, 2023) revenues exceeding $11 million, with significant contributions from  RKings Tournament Competitions, the company’s B2C segment operating in the United Kingdom. “July marked our best monthly financial results at RKings since it was acquired almost two years ago,” said Golden Matrix CEO Brian Goodman. “It contributed $7.5 million toward total revenues in the quarter, which is $1 million more than contributions of about $6.5 million generated in both Q1 and Q2.” According to Mr. Goodman, operational improvements at RKings accounted for its upbeat...

The Company Will Host a Conference Call on Thursday, August 24, 2023, at 9:00 a.m. Eastern Time Tel Aviv, Israel, Aug. 11, 2023 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of enterprise and consumers internet access solutions, will release its financial results for the second quarter ended June 30, 2023, before the Nasdaq market opens on Thursday, August 24, 2023. Mr. Shachar Daniel, Chief Executive Officer of the Company, and Mr. Shai Avnit, Chief Financial Officer of the Company, will host a conference call on August 24, 2023, at 9:00 a.m. Eastern time, to discuss the financial results, followed by a Q&A session. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your call five minutes before...